Cell Isolation/Cell Separation Market by Product, Cell Type, Cell Source, Technique, Application, End-User

Description

List of Tables

[197 Pages Report] The Cell Isolation/Cell Separation Market size was estimated at USD 11.32 billion in 2023 and expected to reach USD 12.93 billion in 2024, at a CAGR 14.44% to reach USD 29.12 billion by 2030.

Cell isolation, also known as cell separation, is a pivotal process in life sciences and medical research, enabling the extraction and separation of specific cell types from a heterogeneous mixture for further analysis, research, or therapeutic use. This process is crucial in various applications including cancer research, stem cell research, immunology, and tissue regeneration. The expansion of its use is primarily driven by technological advancements facilitating higher purity and yield in cell therapy, increasing the prevalence of chronic diseases necessitating personalized medicine, and growing investments in cell-based research. However, the process can be technically challenging, expensive, and time-consuming, with potential risks of cell damage or loss. Addressing these issues, ongoing efforts focus on developing more efficient, cost-effective, and gentle separation techniques, incorporating automation and microfluidic technologies. Cell isolation is poised for significant growth, with opportunities emerging in the development of novel therapeutic applications, integration with artificial intelligence for improved efficiency, and the advent of single-cell technologies offering unparalleled insights into cell function and disease mechanisms.

KEY MARKET STATISTICS
Base Year [2023]	USD 11.32 billion
Estimated Year [2024]	USD 12.93 billion
Forecast Year [2030]	USD 29.12 billion
CAGR (%)	14.44%

Product: Use of consumables to ensure consistency and reliability in results

Consumables are vital to the cell isolation process, offering the necessary reagents and materials for effective separation. This segment is further divided into reagents, beads, and disposables. Reagents include enzymes and buffer solutions critical for cell lysis and separation. Beads, or magnetic beads, offer a method for cell sorting using magnetic fields. Disposables cover a range of products like filters and plates. Instruments in cell isolation encompass devices used in the separation and collection of specific cell types. This segment can be divided into centrifuges, flow cytometers, magnetic-activated cell sorters (MACS), and filtration systems. The preference between these instruments is dictated by the cell isolation method and the desired outcome. Centrifuges are commonly used for basic cell separation needs, whereas flow cytometers and MACS offer higher precision for sorting specific cell types. Filtration systems are preferred for large-volume separations.

End-User: Exponential adoption of cell isolation procedures by research institutes

Biotechnology and biopharmaceutical companies represent a major segment of the cell isolation market. These entities primarily focus on the development of therapeutics, vaccines, and research into novel drug modalities. These companies prioritize automated, high-throughput systems that can handle large volumes without compromising the quality of cell separation. Hospitals and diagnostic laboratories utilize cell isolation for various purposes, including diagnostic assays, clinical trials, and personalized medicine. This segment focuses on accuracy, reliability, and speed to aid in diagnosis and treatment decision-making. These users need easy-to-use, robust systems that can deliver rapid results. Equipment that integrates seamlessly with existing workflows and requires minimal operator training is preferred. Research laboratories and institutes are at the forefront of basic and applied research involving cell-based studies. Their needs center around versatility, sensitivity, and the ability to isolate rare cell populations for research into diseases, regenerative medicine, and more. These entities prefer modular systems that offer a wide range of capabilities, including the isolation of various cell types and the ability to adapt to different research needs.

Regional Insights

In the Americas, there is a strong emphasis on advanced research methodologies and the utilization of cell separation technologies in the biotechnology and pharmaceutical sectors, propelled by substantial investments in healthcare and a robust biotech startup ecosystem. Regional companies are dominating the region, benefitting from a well-established infrastructure and a significant focus on innovation and technological advancement. The APAC region is witnessing rapid growth in the adoption of cell isolation technologies, primarily due to increasing government investment in biotechnology research, burgeoning biotech enterprises, and a rising focus on personalized medicine. However, the region faces challenges in terms of production capabilities and technical sophistication, with companies striving to match the technological prowess seen in Western counterparts. The EMEA region presents a mixed scenario, with Europe at the forefront in terms of research and development activities driven by strong governmental support. The Middle East and Africa are slowly emerging as potential markets, owing to increasing healthcare expenditure and awareness. Companies in EMEA are pivotal in driving innovation, although they face stiff competition from global giants and emerging players in APAC.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Cell Isolation/Cell Separation Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Cell Isolation/Cell Separation Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Cell Isolation/Cell Separation Market, highlighting leading vendors and their innovative profiles. These include Akadeum Life Sciences, Alfa Laval AB, Beckman Coulter, Inc., Becton Dickinson and Company, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, BioLegend, Inc. by PerkinElmer Inc., Capricorn Scientific, CD Bioparticles, Corning Incorporated, Cytiva by Global Life Sciences Solutions USA LLC, F. Hoffmann-La Roche Ltd, GE HealthCare Technologies Inc., GenScript Biotech Corporation, IDEX Health & Science LLC, Invent Biotechnologies, Inc., LeanGene, Merck KGA, MiCareo Inc., Miltenyi Biotec B.V. & Co. KG, NVIGEN, Inc., pluriSelect Life Science UG & Co. KG, Promega Corporation, PromoCell GmbH, Proteintech Group, Inc., Sartorius AG, STEMCELL Technologies Inc., Takara Bio Inc., Terumo BCT, Inc., and Thermo Fisher Scientific, Inc..

Market Segmentation & Coverage

This research report categorizes the Cell Isolation/Cell Separation Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product
- Consumables
  - Beads
  - Disposables
  - Reagents, Kits, Media, & Sera

Instruments
- Centrifuges
- Filtration Systems
- Flow Cytometers
- Magnetic-Activated Cell Separator Systems

Cell Type
- Animal Cells
- Human Cells
  - Differentiated Cells
  - Stem Cells
Cell Source
- Adipose Tissue
- Bone Marrow
- Cord Blood or Embryonic Stem Cells

Technique
- Centrifugation-Based Cell Isolation
- Filtration-Based Cell Isolation
- Surface Marker-Based Cell Isolation

Application
- Biomolecule Isolation
- Cancer Research
- In Vitro Diagnostics
- Stem Cell Research
- Tissue Regeneration & Regenerative Medicine

End-User
- Biotechnology & Biopharmaceutical Companies
- Hospitals & Diagnostic Laboratories
- Research Laboratories & Institutes

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam

Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Cell Isolation/Cell Separation Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Cell Isolation/Cell Separation Market?

3. What are the technology trends and regulatory frameworks in the Cell Isolation/Cell Separation Market?

4. What is the market share of the leading vendors in the Cell Isolation/Cell Separation Market?

5. Which modes and strategic moves are suitable for entering the Cell Isolation/Cell Separation Market?

Product Code: MRR-034230D3E62F

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Significant government funding supporting cell-based research
  - 5.1.1.2. Increasing number of patients suffering from cancer and infectious diseases
- 5.1.2. Restraints
  - 5.1.2.1. High cost associated with cell-based research
- 5.1.3. Opportunities
  - 5.1.3.1. Growing focus on personalized medicine and targeted therapies
  - 5.1.3.2. Development of automated technologies for cell-based therapeutics and

bioprocessing

5.1.4. Challenges
- 5.1.4.1. Ethical issues related to embryonic stem cell isolation

5.2. Market Segmentation Analysis
- 5.2.1. Product: Use of consumables to ensure consistency and reliability in results
- 5.2.2. End-User: Exponential adoption of cell isolation procedures by research institutes
5.3. Market Disruption Analysis
5.4. Porter's Five Forces Analysis
- 5.4.1. Threat of New Entrants
- 5.4.2. Threat of Substitutes
- 5.4.3. Bargaining Power of Customers
- 5.4.4. Bargaining Power of Suppliers
- 5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis

6. Cell Isolation/Cell Separation Market, by Product

6.1. Introduction
6.2. Consumables
6.3. Instruments

7. Cell Isolation/Cell Separation Market, by Cell Type

7.1. Introduction
7.2. Animal Cells
7.3. Human Cells

8. Cell Isolation/Cell Separation Market, by Cell Source

8.1. Introduction
8.2. Adipose Tissue
8.3. Bone Marrow
8.4. Cord Blood or Embryonic Stem Cells

9. Cell Isolation/Cell Separation Market, by Technique

9.1. Introduction
9.2. Centrifugation-Based Cell Isolation
9.3. Filtration-Based Cell Isolation
9.4. Surface Marker-Based Cell Isolation

10. Cell Isolation/Cell Separation Market, by Application

10.1. Introduction
10.2. Biomolecule Isolation
10.3. Cancer Research
10.4. In Vitro Diagnostics
10.5. Stem Cell Research
10.6. Tissue Regeneration & Regenerative Medicine

11. Cell Isolation/Cell Separation Market, by End-User

11.1. Introduction
11.2. Biotechnology & Biopharmaceutical Companies
11.3. Hospitals & Diagnostic Laboratories
11.4. Research Laboratories & Institutes

12. Americas Cell Isolation/Cell Separation Market

12.1. Introduction
12.2. Argentina
12.3. Brazil
12.4. Canada
12.5. Mexico
12.6. United States

13. Asia-Pacific Cell Isolation/Cell Separation Market

13.1. Introduction
13.2. Australia
13.3. China
13.4. India
13.5. Indonesia
13.6. Japan
13.7. Malaysia
13.8. Philippines
13.9. Singapore
13.10. South Korea
13.11. Taiwan
13.12. Thailand
13.13. Vietnam

14. Europe, Middle East & Africa Cell Isolation/Cell Separation Market

14.1. Introduction
14.2. Denmark
14.3. Egypt
14.4. Finland
14.5. France
14.6. Germany
14.7. Israel
14.8. Italy
14.9. Netherlands
14.10. Nigeria
14.11. Norway
14.12. Poland
14.13. Qatar
14.14. Russia
14.15. Saudi Arabia
14.16. South Africa
14.17. Spain
14.18. Sweden
14.19. Switzerland
14.20. Turkey
14.21. United Arab Emirates
14.22. United Kingdom

15. Competitive Landscape

15.1. Market Share Analysis, 2023
15.2. FPNV Positioning Matrix, 2023
15.3. Competitive Scenario Analysis
- 15.3.1. Akadeum Life Sciences Unveils Cutting-Edge Microbubble Instrumentation
- 15.3.2. The LeviCell EOS System for Next-Gen High-Precision Cell Isolation
- 15.3.3. Multiply Labs and Thermo Fisher's Strategic Alliance to Enhance Cell Expansion and Separation
15.4. Strategy Analysis & Recommendation

16. Competitive Portfolio

16.1. Key Company Profiles
16.2. Key Product Portfolio